期刊文献+

戊酸雌二醇对建立人工周期的作用 被引量:11

Effect of progynova in patients with irregular menstruation
下载PDF
导出
摘要 目的:通过观察戊酸雌二醇(商品名称为补佳乐)、安宫黄体酮序贯疗法对月经不调的疗效,探讨其对建立人工周期的作用。方法:将2003年3月-2005年2月来我院门诊的192例月经不调患者按病因不同分为青春期功血、卵巢早衰性闭经及围绝经期功血3组,采用戊酸雌二醇(补佳乐)、安宫黄体酮序贯治疗3-6个周期后,观察患者症状及用药前后血清激素水平。结果:所有病例停药后均发生少、中量撤退性出血,出血时间(5±2.5)天,青春期功血组停药后月经周期恢复正常者占56,9%;卵巢早衰组占9.3%;围绝经期功血组为20.2%,与用药前相比,各组血清激素水平有显著性变化(P〈0.05),后两组更年期症状明显改善(P〈0.05)。结论:戊酸雌二醇(补佳乐)人工周期治疗月经不调患者可使其恢复正常月经周期,调节H-P-O轴功能,同时对卵巢早衰和围绝经期的全身并发症亦有显著疗效。 Objective: To evaluate the effect of progynova and medroxyprugesterune acetate in patients with irregular menstruation. Methods: 192 patients with irregular menstruation were divided into 3 groups by etiopathogenisis, group of adolescent dysfunctional uterine bleeding, group of premature ovarian failure and group of perimenopausal. All patients received 1 mg progynova and 8 mg medroxyprogesterone acetate daily in cyclic sequential regimen. The duration of treatment was 3-6 cycles. Climacteric symptoms were scored before and after treatment. Serum FSH, LH, estradiol and progestogen level were measured at the same time. Results: Withdrawal bleeding occurred in each patient. Time of bleeding was 5±2. 5 days. After stopping cyclic sequential regimen, the recovery rate of normal menstruation cycle in group of adolescent dysfunctional uterine bleeding, group of premature ovarian failure and group of perimenopausal were 56.9% , 9. 3% and 20. 2% respectively. Serum hormone level increased significantly ( P 〈 0. 05 ) pre- and post -therapy in each group. Climacteric symptoms were relieved significantly (P 〈 0. 05 ) both in group of premature ovarian failure and group of perimenopausal. Conclusion: Progynova can adjust cycle of menstruation and relieve climacteric symptoms.
出处 《中国妇幼保健》 CAS 北大核心 2006年第12期1678-1680,共3页 Maternal and Child Health Care of China
关键词 戊酸雌二醇 青春期 功能失调性子宫出血 围绝经期 卵巢早衰 Progynova Puberty Dysfunctional uterine bleeding Perimenopausal Premature ovarian failure
  • 相关文献

参考文献8

  • 1黄荷凤,侯宁宁.性激素替代治疗的适应证和禁忌证[J].中国实用妇科与产科杂志,2004,20(8):450-453. 被引量:10
  • 2林守清 徐苓.女性生殖内分泌性激素补充疗法[M].北京:中国协和医科大学出版社,1999.36-136.
  • 3白书忠.临床药物治疗学[M].北京:人民军医出版社,2001.719.
  • 4朱楣光.功能失调性子宫出血的病因及其病理生理[J].中国实用妇科与产科杂志,2004,20(4):193-194. 被引量:35
  • 5Chen BH,Giudice LC.Desfunctional uterine bleeding.West J Med,1998,169 (5):280
  • 6Rossouw JE,Anderson GL,Prentice RL et al.Risks and benefits of estrogen plus progestin in healthy post menopausal woman:principal results from the Womam's Health Initiative randomized controlled trial.JAMA,2002,288 (3):321
  • 7Anasti JN.Premature ovarian failure:an update.Fertil Steril,1998,70 (1):1
  • 8Staland B,Continuous treatment with a combination of estrogen and gestogen-a way of avoiding endometrial stimulation.Acta Obstet Gynecol Scand,1985,130:29

二级参考文献14

  • 1葛秦生 见:葛秦生 连利娟主编.功能失调性子宫出血[A].见:葛秦生,连利娟主编.生殖内分泌与妇产科疾病诊治手册[C].北京:中国协和医科大学出版社,2002.409-410.
  • 2Colacurci N,De Franciscis P,Cobellis L,et al.Effects of hormone replacement therapy on postmenopausal uterine myoma.Maturitas,2000,35(2):167-173
  • 3Palomba S,Sena T,Morelli M,et al.Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.Eur J Obstet Gynecol Reprod Biol,2002,102(2):199-201
  • 4Matorras R,Elorriaga MA,Pijoan JI,et al.Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy.Fertil Steril,2002,77(2):303-308
  • 5Lundstrom E,Wilczek B,von Pallfy Z,et al.Mammographic breast density during hormone replacement therapy:effects of continuous combination,unopposed transdermal and low-potency estrogen regimens.Climacteric,2001,4(1):42-48
  • 6Yenen MC,Dede M,Goktolga U,et al.Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy.Climacteric,2003,6(2):146-150
  • 7Ferrara A,Karter AJ,Ackerson LM,et al.Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes:the Northern California Kaiser Permanente Diabetes Registry.Diabetes Care,2001,24(7):1144-1150
  • 8Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial.JAMA,2002,288(3):321-333
  • 9Baber RJ,O'Hara JL,Boyle FM,et al.Hormone replacement therapy:to use or not to use? Med J Aust,2003,178(12):630-633
  • 10Van Gorp T,Neven P.Endometrial safety of hormone replacement therapy:review of literature.Maturitas,2002,42(2):93-104

共引文献67

同被引文献57

引证文献11

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部